Targeting the junction of CɛmX and ɛ-migis for the specific depletion of mIgE-expressing B cells.
暂无分享,去创建一个
Herren Wu | P. Kiener | P. Chowdhury | R. Herbst | R. Ettinger | Yan Chen | Kimberly E. Cook | A. Nyborg | Chunning Yang
[1] Min Xu,et al. Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice. , 2010, The Journal of clinical investigation.
[2] F. Tsai,et al. Genetic variations in the CεmX domain of human membrane-bound IgE , 2010, Immunogenetics.
[3] Hwan-You Chang,et al. Unique Epitopes on CεmX in IgE–B Cell Receptors Are Potentially Applicable for Targeting IgE-Committed B Cells , 2010, The Journal of Immunology.
[4] E. Clair. Good and bad memories following rituximab therapy. , 2010 .
[5] Andreas Radbruch,et al. Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge. , 2009, The Journal of allergy and clinical immunology.
[6] Herren Wu,et al. Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors. , 2009, Neoplasia.
[7] D. Keskin,et al. A review of the current use of rituximab in autoimmune diseases. , 2009, International immunopharmacology.
[8] D. Isenberg,et al. Prolonged B-cell depletion following rituximab therapy in systemic lupus erythematosus: a report of two cases , 2008, Annals of the rheumatic diseases.
[9] R. Crameri,et al. Targeting the Extracellular Membrane-Proximal Domain of Membrane-Bound IgE by Passive Immunization Blocks IgE Synthesis In Vivo1 , 2008, The Journal of Immunology.
[10] B. Collins-Burow,et al. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma , 2007, Expert review of anticancer therapy.
[11] J. Friedberg,et al. B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny. , 2007, Clinical immunology.
[12] E. H. Cohen,et al. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity , 2005, Nature Biotechnology.
[13] P. Belliveau. Omalizumab: a monoclonal anti-IgE antibody. , 2005, MedGenMed : Medscape general medicine.
[14] Stanley N Cohen,et al. EST-based genome-wide gene inactivation identifies ARAP3 as a host protein affecting cellular susceptibility to anthrax toxin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Kavuru,et al. Omalizumab: where does it fit into current asthma management? , 2004, Cleveland Clinic journal of medicine.
[16] S. Leppla,et al. Anthrax toxin triggers endocytosis of its receptor via a lipid raft–mediated clathrin-dependent process , 2003, The Journal of cell biology.
[17] Fu-Tong Liu,et al. Monoclonal Antibodies against the CεmX Domain of Human Membrane-Bound IgE and Their Potential Use for Targeting IgE-Expressing B Cells , 2002, International Archives of Allergy and Immunology.
[18] W. Fokkens,et al. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. , 2000, The European respiratory journal.
[19] L. Nitschke,et al. Effect of transmembrane and cytoplasmic domains of IgE on the IgE response. , 1997, Science.
[20] A. Togias,et al. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. , 1997, Journal of immunology.
[21] I. Pastan,et al. Isolation of anti-mesothelin antibodies from a phage display library. , 1997, Molecular immunology.
[22] T. Chang,et al. Structural features of the extracellular portion of membrane-anchoring peptides on membrane-bound immunoglobulins. , 1996, Molecular immunology.
[23] M. Reth,et al. B cell antigen receptors. , 1994, Current opinion in immunology.
[24] D. Parker. T cell-dependent B cell activation. , 1993, Annual review of immunology.
[25] E. E. Max,et al. Two unusual forms of human immunoglobulin E encoded by alternative RNA splicing of epsilon heavy chain membrane exons , 1992, The Journal of experimental medicine.
[26] T. Chang,et al. A new isoform of human membrane-bound IgE. , 1992, Journal of immunology.
[27] T. Chang,et al. An Epitope on Membrane-Bound But Not Secreted IgE: Implications in Isotype-Specific Regulation , 1991, Bio/Technology.
[28] D. MacGlashan,et al. Monoclonal Antibodies Specific for Human IgE-Producing B Cells: A Potential Therapeutic for IgE-Mediated Allergic Diseases , 1990, Bio/Technology.
[29] J. L. Smith,et al. Crystal structure of core streptavidin determined from multiwavelength anomalous diffraction of synchrotron radiation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[30] S L Morrison,et al. Regulation of the production of secretory and membrane immunoglobulin during lymphocyte development. , 1989, Clinical immunology and immunopathology.